CN108355067A - The Chinese medicine for the treatment of cancer ascites - Google Patents
The Chinese medicine for the treatment of cancer ascites Download PDFInfo
- Publication number
- CN108355067A CN108355067A CN201810348457.XA CN201810348457A CN108355067A CN 108355067 A CN108355067 A CN 108355067A CN 201810348457 A CN201810348457 A CN 201810348457A CN 108355067 A CN108355067 A CN 108355067A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- cancer
- ascites
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of Chinese medicine for the treatment of cancer ascites, which is configured by following raw material：13 parts of motherwort, 13 parts of the stem of noble dendrobium, 13 parts of Sculellaria barbata, 13 parts of ganoderma lucidum, 13 parts of oldenlandia diffusa, 13 parts of radix bupleuri, false 280 320 parts of taro, 24 parts of dandelion, 24 parts of Asiatic plantain, 24 parts of green pepper mesh, 24 parts of Herba Lycopi, 46 parts of Rhizoma Gastrodiae, 46 parts of cassia seed；Chinese medicine of the present invention has apparent effect for ascites significant effect caused by treatment kinds cancer, and for inhibiting the growth of cancer cell, diffusion and transfer also.
Description
Technical field
The present invention relates to a kind of drug for the treatment of cancer ascites more particularly to a kind of treatments prepared as raw material using Chinese herbal medicine
The Chinese medicine of cancer ascites.
Background technology
Since the 21th century, malignant tumour (it has often been said that cancer) have become seriously endanger human health disease it
One, it is referred to as incurable disease, is the difficult medical problem of the world today.WHO Report shows, the incidence of cancer and
The death rate rises year by year, and in the late three decades, world's cancer morbidity is with the speed increase of average annual 3-5%, treating cancer at present
Drug or method effect are not ideal, and cancer has become first cause of the death of the mankind.
Most of cancer patients showing for seroperitoneum (abbreviation ascites), the especially middle and advanced stage of cancer can occur particularly
Obviously；The formation of seroperitoneum is the generation of intraperitoneal liquid and absorption loses dynamic equilibrium as a result, each disease abdominal cavity is accumulated
The Forming Mechanism of liquid is caused by several factors in combination or independent role.At present for the treatment and elimination of cancer ascites, doctor trained in Western medicine does not have
There is more effective therapy, except diuretic therapy is used, mainly takes the method that intracavitary is drawn water except ponding of dispelling, and it is a kind of to draw water
Emergent measure, although the liquid of a part of lesion can be taken out, some nutritional ingredients present in liquid are also taken out together
Go out：And be also possible to generate infection, some side effects such as pain during drawing water, exhaust must supplement human body after hydrops must
The albumen and other nutriments of palpus increase Case treatment burden, and patient's pain；Also, repeatedly drawing water not only makes patient
Pain aggravates, wound easy infection, and since the albumen that patient's ascites contains is extracted out with ascites, patient body is made more to lack egg
In vain, it is such as supplemented albumen, not only therapeutic equipment is made to extend, financial burden is further increased, and frequently use diuretics, easily leads to kidney
Functional failure makes patient be absorbed in the stage that can not be treated.
Therefore, there is an urgent need for a kind of Chinese medicines for capableing of safe and effective treating cancer ascites will be with important clinical valence.
Invention content
The purpose of the present invention is to provide a kind of Chinese medicines for the treatment of cancer ascites, by selecting suitable medicinal material and its matching
Than achieving the purpose that safe and effective treating cancer ascites.
To achieve the above object, the present invention provides a kind of Chinese medicine for the treatment of cancer ascites, the Chinese medicines, by following parts by weight
Raw material configures：1-3 parts of motherwort, 1-3 parts of the stem of noble dendrobium, 1-3 parts of Sculellaria barbata, 1-3 parts of ganoderma lucidum, 1-3 parts of oldenlandia diffusa, radix bupleuri
1-3 parts, false 280-320 parts of taro, 2-4 parts of dandelion, 2-4 parts of Asiatic plantain, 2-4 parts of green pepper mesh, 2-4 parts of Herba Lycopi, 4-6 parts of Rhizoma Gastrodiae,
4-6 parts of cassia seed.
According to the plus-minus heteropathy of Chinese medicine, situations such as according to the constitution and symptom of patient, it is above-mentioned per taste Chinese medicine material all
It can be adjusted within the scope of the number provided, take numerical value appropriate to reach best therapeutic effect.
Preferably, the Chinese medicine for the treatment of cancer ascites of the present invention, is configured by following raw material：1 part of motherwort, stone
1 part of dry measure used in former times, 3 parts of Sculellaria barbata, 2 parts of ganoderma lucidum, 3 parts of oldenlandia diffusa, 3 parts of radix bupleuri, false 320 parts of taro, 2 parts of dandelion, Asiatic plantain 3
Part, 4 parts of green pepper mesh, 2 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 6 parts of cassia seed.
Preferably, the Chinese medicine for the treatment of cancer ascites of the present invention, is configured by following raw material：2 parts of motherwort, stone
1 part of dry measure used in former times, 3 parts of Sculellaria barbata, 3 parts of ganoderma lucidum, 2 parts of oldenlandia diffusa, 1 part of radix bupleuri, false 320 parts of taro, 2 parts of dandelion, Asiatic plantain 4
Part, 3 parts of green pepper mesh, 4 parts of Herba Lycopi, 6 parts of Rhizoma Gastrodiae, 4 parts of cassia seed.
Preferably, the Chinese medicine for the treatment of cancer ascites of the present invention, is configured by following raw material：2 parts of motherwort, stone
2 parts of dry measure used in former times, 2 parts of Sculellaria barbata, 2 parts of ganoderma lucidum, 2 parts of oldenlandia diffusa, 2 parts of radix bupleuri, false 300 parts of taro, 3 parts of dandelion, Asiatic plantain 3
Part, 3 parts of green pepper mesh, 3 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 4 parts of cassia seed.
Preferably, the Chinese medicine for the treatment of cancer ascites of the present invention, is configured by following raw material：3 parts of motherwort, stone
3 parts of dry measure used in former times, 1 part of Sculellaria barbata, 1 part of ganoderma lucidum, 1 part of oldenlandia diffusa, 1 part of radix bupleuri, false 280 parts of taro, 4 parts of dandelion, Asiatic plantain 2
Part, 2 parts of green pepper mesh, 3 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 5 parts of cassia seed.
Raw material pharmacology efficiency analysis selected by the present invention is as follows：
The effect of motherwort：Promoting blood circulation for regulating menstruation, inducing diuresis to remove edema, clearing heat and detoxicating effect.
The effect of stem of noble dendrobium:Dredge clearind deficient heat, strengthen the spleen and stomach, strong muscles and bones the effect of.
The effect of Sculellaria barbata：The effect of clearing heat and detoxicating, promoting blood circulation, inducing diuresis to remove edema.
The effect of ganoderma lucidum：Invigorating qi for tranquilization, relieving cough and asthma, the effect of promoting longevity.
The effect of oldenlandia diffusa：The effect of clearing heat and detoxicating, medicinal powder for relieving pain knot, promoting urination and removing dampness.
The effect of radix bupleuri：Evacuation brings down a fever, stops the effect of malaria, soothing liver-qi stagnation.
The effect of false taro：(alias：Wild taro, kwan-yin taro, guangdong chamaejasme) clearing heat and detoxicating, dispersing swelling and dissipating binds, treat cancerous swelling poison
Effect.
The effect of dandelion：The effect of clearing heat and detoxicating, dispersing swelling and dissipating binds, inducing diuresis for treating strangurtia.
The effect of Asiatic plantain：The effect of diuresis, heat-clearing, improving eyesight, eliminating the phlegm.
Green pepper purpose effect：The effect of inducing diuresis for removing edema, eliminating phlegm and relieving asthma, main oedema turgor, asthma.
The effect of Herba Lycopi：Promoting circulation of blood diuresis dissipates the effect of Yu Shu livers.
The effect of Rhizoma Gastrodiae：Inflammation Zhijing, it is calming the liver, the effect of dispelling wind and removing obstruction in the meridians.
The effect of cassia seed：The effect of clearing liver and improving vision, relaxing bowel.
Traditional Chinese medicine compatibility in the present invention have clearing heat and detoxicating, dispersing swelling and dissipating binds, treat cancerous swelling poison, invigorating qi for tranquilization, inducing diuresis to remove edema,
Tonification and purgation in combination and other effects, has remarkable effect for inhibiting cancer ascites and eliminating cancer ascites, and be incorporated big number
False taro, the effect for further improving clearing heat and detoxicating, dispersing swelling and dissipating binds, treating cancerous swelling poison so that inhibiting and eliminating cancer ascites
While the effect of also having both treating cancer tumour, for inhibiting the growth, diffusion and transfer of cancer cell that also there is apparent make
With the party, which is applied to tumor area, can enhance the immune function of cancer patients, improve constitution, improve anti-cancer ability.This is controlled
The step for the treatment of the preparation method of the Chinese medicine of cancer ascites is as follows：(1) each raw material is put into according to proportioning and fills 20 times of part weight waters
Marmite in；(2) to marmite heating up to boiling water in marmite；(3) small fire is gone in marmite after boiling water to stew at least 4 hours,
Until when water is 6 times of part weight of raw material in marmite, stop heating marmite.(4) it after marmite cooling, filters out in marmite
The dregs of a decoction pour out decoction and are divided into three parts of fresh-keeping preservations of progress, and patient drinks decoction three times daily, drinks decoction portion every time.
The Chinese medicine that the treating cancer ascites provided is provided, by repeatedly research, refinement, after optimization, be applied to clinical real
It tramples and achieves good effect, for ascites significant effect caused by treatment kinds cancer, and for the life of inhibition cancer cell
Long, diffusion and transfer also have apparent effect.Apparent collaboration has occurred between the active ingredient of each raw material of the present invention to increase
Effect acts on, and can induce or promote the phagocytosis of macrophage, enhances the activity of NK cells, and immunoglobulin is promoted to be formed,
Immunity of organisms is improved, cancer ascites is effectively removed and inhibits the generation of cancer ascites, while killing tumour cell indirectly；And
Also have invigorating qi for tranquilization, it is relieving cough and asthma, clear liver and improve vision, medicinal powder for relieving pain knot the effect of, reach mitigate patient suffering, improve existence matter
Amount, extends the effect in service life.
Below by clinical data come the effect of illustrating Chinese medicine of the present invention：
1, clinical observation：
Chinese medicine of the present invention is accepted for medical treatment and tracked from August, 2015 to 2 months 2018 altogether is diagnosed as cancer and tool through Grade A hospital
There is 46 people of patient of oedema phenomenon, the wherein age is 10,16 of 40-50 Sui, 8,60 years old of 50-60 Sui of 30-40 Sui
Above 12, male to female ratio 1:1.It is collected simultaneously and has tracked 46 cancer patients using chemotherapeutic drug therapy as a comparison
Group takes the drugs such as spiral shell lactones piece, FUSAIMI PIAN, compound hydrochloric acid amiloride piece.
2, therapy：
Instructions of taking：Drunk daily three times using the decoction patient of Traditional Chinese medicine decocting of the present invention, patient it is early, middle and late before meals or
350ml-450ml is drunk in 1 hour after meal.Patient does relevant inspection and records in detail before and after treatment.
Dietetic contraindication：It can simultaneously be used together with the Chinese medicine of another treating cancer of the applicant during treatment, to cancer
Therapeutic effect will more preferably quit smoking, wine and maror.
3, criterion of therapeutical effect：
Significantly：After drug administration, physical recovery；By B ultrasound, CT examination；Ascites is eliminated and tumour is obviously reduced, and is changed
Index is tested to be decreased obviously.
Obviously：After drug administration, ascites is eliminated and tumour does not develop, and symptom improves apparent.
Effectively：After drug administration, ascites significantly reduces.
In vain：After drug administration compared with before drug administration without improvement.
4, efficacy result：
| Total number of persons | Notable number | Apparent number | Efficiently individual quantity | Invalid number | It is efficient | |
| The present invention | 46 | 25 | 10 | 7 | 4 | 91.3% |
| Contrast groups | 46 | 3 | 7 | 31 | 5 | 89.1% |
5, some cases data：
Case 1：Chen, female, 35 years old, Guangdong Province people from Zhanjiang.Hospital diagnosis is poorly differentiated adenocarcinoma, signet ring cell cancer.
One course for the treatment of of in October, 2014 row " stomach radical correction " and systemic chemotherapy, stops chemotherapy afterwards；In November, 2015 physical examination finds diffusion,
There is that ascites is present, and in January, 2016 starts to take Chinese medicine of the present invention, after continuously taking 4 months, hospital is gone to check in December, 2015
Ascites is eliminated and diffusion is suppressed, it is rear and it is continuous take 15 months state of an illness and gradually improve, after fully recover, do not occur abdomen so far
Water, and periodic review every half a year, have no tumour.
Case 2：Sinus so-and-so, man, 42 years old, Guangdong Province people from Dongguan；Hospital diagnosis is later period of hepatocarcinoma, and ascites is serious, advises its time
Family raises, and life cycle is only 4 months at most super.Came here in 2015 4 upon somebody's introduction to seek medical advice；When first visit, patient has liied in bed not
Rise, start to take Chinese medicine of the present invention in May, 2015 after 4 months, can out-of-bed activity, energy muscle power starts to restore, continuously take afterwards
So far, existing ascites substantially reduces, and tumour is obviously reduced, with obvious effects, and follow-up in January, 2018, physical condition is good, can be engaged in letter
Single farm work.
Case 3：Guo so-and-so, man, 48 years old, Dongguan, Guangdong people.Hospital diagnosis outer cancer of the esophagus early stage, in March, 2014, operation was controlled
It treats, the check of in August, 2015 finds diffusion and with there is serious ascites, crisis feature occurs, and dysphagia cannot be fed,
Since hypertension is serious, second of operation can not be carried out, abandons treating.Through its relative sinus, so-and-so (above-mentioned case 2) is introduced, in
In September, 2015 starts to take Chinese medicine of the present invention so far, now has no that ascites, tumour are significantly obviously reduced, and diet is gradually by liquid food, half
Liquid food switchs to normally, and the state of an illness gradually improves, and follow-up in January, 2018, physical condition is good, and diet is normal.
Case 4：Zhang, man, 56 years old, Guangdong Province people from Shaoguan.Hospital diagnosis is advanced lung cancer, unconditional to perform the operation, hospital
It abandons treating, it is allowed to go home to recuperate.Patient feels good after starting to take Chinese medicine of the present invention in March, 2015 upon somebody's introduction, essence
Power muscle power starts to restore, and continuously takes so far afterwards, now has no that ascites, tumour are obviously reduced, with obvious effects, follow-up in January, 2018,
Physical condition is good.
Case 5：Gold so-and-so, female, 62 years old, recluse in Guangdong.Hospital diagnosis ectocervix cancer late period, when having lost operative treatment
Machine cannot also continue to carry out Radiotherapy chemotherapy because weak.Start patient after taking Chinese medicine of the present invention in April, 2016 upon somebody's introduction to feel
Feel good, energy muscle power starts to restore, and continuously takes so far afterwards, now has no that ascites, tumour are obviously reduced, with obvious effects, and 2018
Year follow-up in January, physical condition are good.
6, clinical analysis：
Chinese medicine clinical verification satisfactory effect of the present invention can improve the immune function of body, adjust body equilibrium between yin and yang, for
Ascites caused by treatment kinds cancer, which plays, to be mitigated disease pain, eliminate ascites or reduces the effect of ascites, and can auxiliary treatment
Cancer, for inhibiting the growth, diffusion and transfer of cancer cell that also there is apparent effect.It is each that the Chinese medicine of the present invention is suitable for cancer
There is effective treatment of ascites in a stage, and without apparent side effect, after patient on medication, to the hepatic and renal function of patient,
The routine inspections such as blood routine, stool and urine do not find the anomalous variation because caused by taking Chinese medicine of the present invention, are worth clinical expansion
It uses.
Specific implementation mode
In order to be better understood from and implement the present invention, further illustrated with reference to embodiment.
Embodiment 1：
It weighs：1 gram of motherwort, 1 gram of the stem of noble dendrobium, 3 grams of Sculellaria barbata, 2 grams of ganoderma lucidum, 3 grams of oldenlandia diffusa, 3 grams of radix bupleuri, false taro
320 grams, 2 grams of dandelion, 3 grams of Asiatic plantain, 4 grams of green pepper mesh, 2 grams of Herba Lycopi, 4 grams of Rhizoma Gastrodiae, 6 grams of cassia seed.The preparation method of the Chinese medicine
Steps are as follows：(1) each raw material is put into according to proportioning in the marmite for filling 20 times of part weight waters；(2) to marmite heating until sand
Boiling water in pot；(3) small fire is gone in marmite after boiling water to stew at least 4 hours, until water is 6 times of part weight of raw material in marmite
When, stop heating marmite.(4) after marmite cooling, the dregs of a decoction in marmite is filtered out, decoction is poured out and is divided into three parts of progress
Fresh-keeping preservation, patient drink decoction three times daily, drink decoction portion, every part of 350ml-450ml every time.
Embodiment 2：
It weighs：2 grams of motherwort, 1 gram of the stem of noble dendrobium, 3 grams of Sculellaria barbata, 3 grams of ganoderma lucidum, 2 grams of oldenlandia diffusa, 1 gram of radix bupleuri, false taro
320 grams, 2 grams of dandelion, 4 grams of Asiatic plantain, 3 grams of green pepper mesh, 4 grams of Herba Lycopi, 6 grams of Rhizoma Gastrodiae, 4 grams of cassia seed.The preparation method of the Chinese medicine
Steps are as follows：(1) each raw material is put into according to proportioning in the marmite for filling 20 times of part weight waters；(2) to marmite heating until sand
Boiling water in pot；(3) small fire is gone in marmite after boiling water to stew at least 4 hours, until water is 6 times of part weight of raw material in marmite
When, stop heating marmite.(4) after marmite cooling, the dregs of a decoction in marmite is filtered out, decoction is poured out and is divided into three parts of progress
Fresh-keeping preservation, patient drink decoction three times daily, drink decoction portion, every part of 350ml-450ml every time.
Embodiment 3：
It weighs：2 grams of motherwort, 2 grams of the stem of noble dendrobium, 2 grams of Sculellaria barbata, 2 grams of ganoderma lucidum, 2 grams of oldenlandia diffusa, 2 grams of radix bupleuri, false taro
300 grams, 3 grams of dandelion, 3 grams of Asiatic plantain, 3 grams of green pepper mesh, 3 grams of Herba Lycopi, 4 grams of Rhizoma Gastrodiae, 4 grams of cassia seed.The preparation method of the Chinese medicine
Steps are as follows：(1) each raw material is put into according to proportioning in the marmite for filling 20 times of part weight waters；(2) to marmite heating until sand
Boiling water in pot；(3) small fire is gone in marmite after boiling water to stew at least 4 hours, until water is 6 times of part weight of raw material in marmite
When, stop heating marmite.(4) after marmite cooling, the dregs of a decoction in marmite is filtered out, decoction is poured out and is divided into three parts of progress
Fresh-keeping preservation, patient drink decoction three times daily, drink decoction portion, every part of 350ml-450ml every time.
Embodiment 4：
It weighs：3 grams of motherwort, 3 grams of the stem of noble dendrobium, 1 gram of Sculellaria barbata, 1 gram of ganoderma lucidum, 1 gram of oldenlandia diffusa, 1 gram of radix bupleuri, false taro
280 grams, 4 grams of dandelion, 2 grams of Asiatic plantain, 2 grams of green pepper mesh, 3 grams of Herba Lycopi, 4 grams of Rhizoma Gastrodiae, 5 grams of cassia seed.The preparation method of the Chinese medicine
Steps are as follows：(1) each raw material is put into according to proportioning in the marmite for filling 20 times of part weight waters；(2) to marmite heating until sand
Boiling water in pot；(3) small fire is gone in marmite after boiling water to stew at least 4 hours, until water is 6 times of part weight of raw material in marmite
When, stop heating marmite.(4) after marmite cooling, the dregs of a decoction in marmite is filtered out, decoction is poured out and is divided into three parts of progress
Fresh-keeping preservation, patient drink decoction three times daily, drink decoction portion, every part of 350ml-450ml every time.
It is above disclosed to be merely a preferred embodiment of the present invention, the right of the present invention cannot be limited with this certainly
Range, therefore according to equivalent variations made by scope of the present invention patent, be still within the scope of the present invention.
Claims (5)
1. a kind of Chinese medicine for the treatment of cancer ascites, which is characterized in that configured by following raw material：1-3 parts of motherwort,
1-3 parts of the stem of noble dendrobium, 1-3 parts of Sculellaria barbata, 1-3 parts of ganoderma lucidum, 1-3 parts of oldenlandia diffusa, 1-3 parts of radix bupleuri, false 280-320 parts of taro, Pu
Public English 2-4 parts, 2-4 parts of Asiatic plantain, 2-4 parts of green pepper mesh, 2-4 parts of Herba Lycopi, 4-6 parts of Rhizoma Gastrodiae, 4-6 parts of cassia seed.
2. the Chinese medicine for the treatment of cancer ascites as described in claim 1, which is characterized in that configured by following raw material and
At：1 part of motherwort, 1 part of the stem of noble dendrobium, 3 parts of Sculellaria barbata, 2 parts of ganoderma lucidum, 3 parts of oldenlandia diffusa, 3 parts of radix bupleuri, false 320 parts of taro, Pu Gong
2 parts of English, 3 parts of Asiatic plantain, 4 parts of green pepper mesh, 2 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 6 parts of cassia seed.
3. the Chinese medicine for the treatment of cancer ascites as described in claim 1, which is characterized in that configured by following raw material and
At：2 parts of motherwort, 1 part of the stem of noble dendrobium, 3 parts of Sculellaria barbata, 3 parts of ganoderma lucidum, 2 parts of oldenlandia diffusa, 1 part of radix bupleuri, false 320 parts of taro, Pu Gong
2 parts of English, 4 parts of Asiatic plantain, 3 parts of green pepper mesh, 4 parts of Herba Lycopi, 6 parts of Rhizoma Gastrodiae, 4 parts of cassia seed.
4. the Chinese medicine for the treatment of cancer ascites as described in claim 1, which is characterized in that configured by following raw material and
At：2 parts of motherwort, 2 parts of the stem of noble dendrobium, 2 parts of Sculellaria barbata, 2 parts of ganoderma lucidum, 2 parts of oldenlandia diffusa, 2 parts of radix bupleuri, false 300 parts of taro, Pu Gong
3 parts of English, 3 parts of Asiatic plantain, 3 parts of green pepper mesh, 3 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 4 parts of cassia seed.
5. the Chinese medicine for the treatment of cancer ascites as described in claim 1, which is characterized in that configured by following raw material and
At：3 parts of motherwort, 3 parts of the stem of noble dendrobium, 1 part of Sculellaria barbata, 1 part of ganoderma lucidum, 1 part of oldenlandia diffusa, 1 part of radix bupleuri, false 280 parts of taro, Pu Gong
4 parts of English, 2 parts of Asiatic plantain, 2 parts of green pepper mesh, 3 parts of Herba Lycopi, 4 parts of Rhizoma Gastrodiae, 5 parts of cassia seed.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810348457.XA CN108355067A (en) | 2018-04-18 | 2018-04-18 | The Chinese medicine for the treatment of cancer ascites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810348457.XA CN108355067A (en) | 2018-04-18 | 2018-04-18 | The Chinese medicine for the treatment of cancer ascites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108355067A true CN108355067A (en) | 2018-08-03 |
Family
ID=63008623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810348457.XA Pending CN108355067A (en) | 2018-04-18 | 2018-04-18 | The Chinese medicine for the treatment of cancer ascites |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108355067A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055078A (en) * | 2012-12-26 | 2013-04-24 | 柳州市中医院 | Traditional Chinese medicine for treating ascites hepatoma and preparation method thereof |
| WO2014139282A1 (en) * | 2013-03-11 | 2014-09-18 | Xiao Mingchun | Pharmaceutical compositions for treating cancer of genital system and preparation method therefor |
-
2018
- 2018-04-18 CN CN201810348457.XA patent/CN108355067A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055078A (en) * | 2012-12-26 | 2013-04-24 | 柳州市中医院 | Traditional Chinese medicine for treating ascites hepatoma and preparation method thereof |
| WO2014139282A1 (en) * | 2013-03-11 | 2014-09-18 | Xiao Mingchun | Pharmaceutical compositions for treating cancer of genital system and preparation method therefor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998843A (en) | Medicinal composition for treating cholecystitis | |
| CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN102772781B (en) | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof | |
| CN104940784B (en) | A kind of Chinese medicine composition for treating chronic gastritis | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN109730981A (en) | For treating anorexia, dyspeptic Traditional Chinese medicine composition patch, preparation and its application | |
| CN102614471A (en) | Traditional Chinese medicine for treating breast carcinoma | |
| CN103920102B (en) | A kind of Chinese medicine for treating essential hypotension | |
| CN115487283A (en) | Chinese medicinal preparation for treating heart failure | |
| CN108096555A (en) | A kind of Chinese prescription and its preparation for being used to treat pregnancy period hyperemesis | |
| CN107890521A (en) | A kind of Chinese medicine composition of liver protection and eyesight and its preparation method of pill | |
| CN108355067A (en) | The Chinese medicine for the treatment of cancer ascites | |
| CN111973677A (en) | Traditional Chinese medicine acupoint application formula for abdominal obesity and preparation method and application thereof | |
| CN109078157A (en) | A kind of anti-tumor drug and preparation method thereof | |
| CN104645295A (en) | Traditional Chinese medicine for treating and preventing gastrointestinal cancer | |
| CN100423764C (en) | Tumor-treating oral Chinese medicine composition | |
| CN108355012A (en) | The Chinese medicine for the treatment of cancer | |
| CN105833228A (en) | Drug preparation for reversing gastric cancer drug resistance and application thereof | |
| CN105079661A (en) | Traditional Chinese medicine composition for treating hemafecia | |
| CN104367862A (en) | Traditional Chinese medicinal composition for treating urethral calculus | |
| CN104958684A (en) | Medicine for treating chronic gastritis | |
| CN104367944B (en) | A kind of medicine for treating the protrasion of the lumbar intervertebral disci | |
| CN114732883A (en) | Traditional Chinese medicine composition for invigorating spleen and benefiting stomach and preparation method and application thereof | |
| CN104474353A (en) | Medicine for treating myasthenia gravis and preparation method of medicine | |
| CN114129697A (en) | Yang-invigorating soup and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180803 |